Biomater. Sci., 2025, Advance Article
DOI: 10.1039/D5BM01232E, Paper
DOI: 10.1039/D5BM01232E, Paper
Open Access
  This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Melissa Ling, Nataly Kacherovsky, Abe Y. Wu, Minjian Ni, Jessica A. Hamerman, Suzie H. Pun
CD36-binding aptamer isolated monocytes from peripheral blood mononuclear cells with high purity and yield, minimizing manufacturing costs, activation risks, and immunogenic concerns compared to CD14 antibody.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
CD36-binding aptamer isolated monocytes from peripheral blood mononuclear cells with high purity and yield, minimizing manufacturing costs, activation risks, and immunogenic concerns compared to CD14 antibody.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry
.png)











English (US)